Cognizant and gilead expand partnership to drive greater value through advanced technology applications

Cognizant will provide ai-driven solutions to enhance customer service, employee engagement, and business value teaneck, n.j. , jan. 30, 2025 /prnewswire/ -- cognizant (nasdaq: ctsh) has announced an expansion of its longstanding relationship with biopharmaceutical leader gilead sciences (nasdaq: gild) that aims to unlock even greater value for gilead as it advances innovations to prevent and treat life-threatening diseases.
CTSH Ratings Summary
CTSH Quant Ranking